Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hofseth Biocare ASA ( (HOFBF) ) just unveiled an announcement.
Hofseth BioCare ASA has concluded its subsequent offering, raising approximately NOK 30 million through the issuance of over 1.2 million new ordinary shares. The offering was directed at eligible shareholders, with the board allocating shares accordingly. The completion of this offering is contingent upon the registration of the share capital increase with the Norwegian Register of Business Enterprises and the receipt of payment for all subscribed shares. This move is expected to strengthen the company’s financial position and support its strategic initiatives.
More about Hofseth Biocare ASA
Hofseth BioCare ASA operates in the biotechnology industry, focusing on the production of high-value ingredients from fish by-products. The company is known for its innovative approach to utilizing marine resources, aiming to deliver sustainable and health-promoting products to the market.
Average Trading Volume: 97,468
Current Market Cap: NOK698.8M
For detailed information about HOFBF stock, go to TipRanks’ Stock Analysis page.